CS223842B2 - Method of making the pyridoxin derivatives - Google Patents

Method of making the pyridoxin derivatives Download PDF

Info

Publication number
CS223842B2
CS223842B2 CS813634A CS363481A CS223842B2 CS 223842 B2 CS223842 B2 CS 223842B2 CS 813634 A CS813634 A CS 813634A CS 363481 A CS363481 A CS 363481A CS 223842 B2 CS223842 B2 CS 223842B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
hydroxy
propoxy
formula
compound
Prior art date
Application number
CS813634A
Other languages
Czech (cs)
English (en)
Inventor
Marcel Descamps
Marcel Urbain
Original Assignee
Labaz Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Nv filed Critical Labaz Nv
Publication of CS223842B2 publication Critical patent/CS223842B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS813634A 1980-05-19 1981-05-15 Method of making the pyridoxin derivatives CS223842B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19

Publications (1)

Publication Number Publication Date
CS223842B2 true CS223842B2 (en) 1983-11-25

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
CS813634A CS223842B2 (en) 1980-05-19 1981-05-15 Method of making the pyridoxin derivatives

Country Status (32)

Country Link
US (1) US4374841A (el)
EP (1) EP0040591B1 (el)
JP (1) JPS5711966A (el)
AR (1) AR226356A1 (el)
AT (1) ATE3859T1 (el)
AU (1) AU542463B2 (el)
BG (1) BG35327A3 (el)
CA (1) CA1152080A (el)
CS (1) CS223842B2 (el)
DD (1) DD159071A5 (el)
DE (1) DE3160480D1 (el)
DK (1) DK217481A (el)
EG (1) EG15890A (el)
ES (1) ES502276A0 (el)
FI (1) FI811525L (el)
GR (1) GR82343B (el)
HU (1) HU183441B (el)
IE (1) IE51179B1 (el)
IL (1) IL62602A (el)
IN (1) IN151915B (el)
IS (1) IS1183B6 (el)
MA (1) MA19147A1 (el)
NO (1) NO811680L (el)
NZ (1) NZ196766A (el)
OA (1) OA06811A (el)
PL (1) PL129213B1 (el)
PT (1) PT72992B (el)
RO (1) RO81943A (el)
SU (1) SU1077566A3 (el)
YU (1) YU126281A (el)
ZA (1) ZA812448B (el)
ZW (1) ZW9681A1 (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
CA2376029A1 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003507418A (ja) * 1999-08-24 2003-02-25 メディキュア インターナショナル インコーポレイテッド 心血管疾患とその関連疾患の治療
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
WO2001064692A1 (en) 2000-02-29 2001-09-07 Medicure International Inc. Cardioprotective phosphonates and malonates
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
AU2001272263B2 (en) 2000-07-07 2005-12-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20070167411A1 (en) * 2003-03-27 2007-07-19 Medicure International Inc. Compositions for treating angina
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
CA2585165A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208397A1 (es) * 1973-02-20 1976-12-27 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
ATE3859T1 (de) 1983-07-15
ES8203845A1 (es) 1982-04-01
DK217481A (da) 1981-11-20
EG15890A (en) 1987-03-30
AU542463B2 (en) 1985-02-21
RO81943B (ro) 1983-05-30
NZ196766A (en) 1984-02-03
US4374841A (en) 1983-02-22
PT72992B (en) 1982-07-01
PL231193A1 (el) 1982-07-05
JPS5711966A (en) 1982-01-21
MA19147A1 (fr) 1981-12-31
IN151915B (el) 1983-09-03
AR226356A1 (es) 1982-06-30
AU7053581A (en) 1981-11-26
ZW9681A1 (en) 1982-01-20
DE3160480D1 (en) 1983-07-28
IS2631A7 (is) 1981-11-11
PL129213B1 (en) 1984-04-30
GR82343B (el) 1984-12-13
FI811525L (fi) 1981-11-20
CA1152080A (en) 1983-08-16
IE811085L (en) 1981-11-19
BG35327A3 (en) 1984-03-15
RO81943A (ro) 1983-06-01
IL62602A0 (en) 1981-06-29
HU183441B (en) 1984-05-28
EP0040591B1 (fr) 1983-06-22
OA06811A (fr) 1982-12-31
IE51179B1 (en) 1986-10-29
DD159071A5 (de) 1983-02-16
EP0040591A1 (fr) 1981-11-25
YU126281A (en) 1984-02-29
NO811680L (no) 1981-11-20
SU1077566A3 (ru) 1984-02-29
IS1183B6 (is) 1985-05-13
ES502276A0 (es) 1982-04-01
IL62602A (en) 1984-06-29
PT72992A (en) 1981-06-01
ZA812448B (en) 1982-04-28

Similar Documents

Publication Publication Date Title
CS223842B2 (en) Method of making the pyridoxin derivatives
KR100837420B1 (ko) 5-히드록시-인돌-3-카르복시산에스테르 유도체 및 이의용도
EP3196197A1 (en) Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor
US4460586A (en) 2-Cyano-4-(2-hydroxy-3-substituted-aminopropoxy) indoles
EA002778B1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
EP0370901A1 (fr) Nouveaux dérivés du chromanne actifs sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques en contenant
CA2325587A1 (en) Imidazolone anorectic agents: ii. phenyl derivatives
HUT65489A (en) Process for producing of indole derivatives and pharmaceutical compositions comprising them
EA021904B1 (ru) Производные хиноксалинона в качестве стимуляторов секреции инсулина, способы их получения и их применение для лечения диабета
CZ397598A3 (cs) Derivát 5-fenoxyalkyl-2,4-thiazolidindionu, způsob jeho přípravy, meziprodukty pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
FR2639942A1 (fr) Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
IE50186B1 (en) 3-aminopropoxy derivatives,their preparation and pharmaceutical compositions containing them
DK160820B (da) Analogifremgangsmaade til fremstilling af 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinolinderivater
BG61318B2 (bg) N-2/(4-флуорофенил)-1-метил/-2-етил-n-метил-n-пропиниламин и метод за използването му
US5034411A (en) Novel 4-cyanophenyl derivatives with action against cardiac arrhythmia
NO155880B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-beta-fenylpropionfenon.
US4235919A (en) 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
JPS6340784B2 (el)
EP0348257A2 (fr) Nouveaux dérivés d'(hétéro)aryl diazole, leur procédé de préparation et leur application en thérapeutique
CS216525B2 (en) Method of making the phenylpiperazine derivatives
US4067873A (en) Certain 1-amino-3-(1-isoquinolinyl)oxy-2-propanol derivatives
US4071630A (en) 1-Substituted-amino-3-(4-furo[3,2-c]pyridinyloxy)-2-propanols
US3479371A (en) 3-((1-cyano-2-lower alkyl)amino)-2-hydroxypropoxyindoles
US4574127A (en) Oxazoles and thiazoles containing an aminohydroxypropoxyphenyl moiety
US4278798A (en) 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxonicotinic acid and esters thereof